YWHAE-NUTM2A/B Translocated High-grade Endometrial Stromal Sarcoma Commonly Expresses CD56 and CD99
Authors:
- Cheng-Han LeeCLCheng-Han Lee
- 1 November 2019
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 38 (6) , 528-532
Abstract
YWHAE-NUTM2A/B translocated high-grade endometrial stromal sarcoma is an uncommon and clinically aggressive uterine mesenchymal neoplasm which is sometimes associated with a low-grade fibromyxoid component. Although the diagnosis is confirmed using molecular techniques, it is possible to make the diagnosis based on the characteristic morphology and the immunophenotype; the latter typically includes diffuse positive staining of the high-grade component with cyclin D1 and CD117 and negative staining with CD10 and hormone receptors. Especially in a small biopsy specimen, in cases without a low-grade component or when presenting with extrauterine disease, the differential diagnosis may be wide and potentially include “small round cell tumors” such as a high-grade neuroendocrine carcinoma and a tumor in the Ewing family. In this study, we report consistent CD56 and CD99 immunoreactivity in YWHAE-NUTM2A/B translocated high-grade endometrial stromal sarcoma. We stained 20 of these neoplasms (10 molecularly confirmed and 10 where diagnosis was based on the morphology and immunophenotype) with CD56 and CD99; in one case, CD56 staining was not performed. Nineteen of 19 (100%) and 17 of 20 (85%) were positive with CD56 and CD99, respectively. Staining was usually diffuse with membranous and cytoplasmic immunoreactivity. Pathologists should be aware that YWHAE-NUTM2A/B translocated high-grade endometrial stromal sarcoma is commonly positive with CD56 and CD99; as well as potentially assisting in diagnosis, positivity with these markers may also result in consideration of other neoplasms in the differential diagnosis.Keywords
This publication has 13 references indexed in Scilit:
- Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerationsPathology, 2018
- BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphologyLaboratory Investigation, 2017
- Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescentsHuman Pathology, 2017
- The application of next‐generation sequencing‐based molecular diagnostics in endometrial stromal sarcomaHistopathology, 2016
- Endometrial stromal sarcoma – the new genetic paradigmHistopathology, 2015
- Ewing's sarcoma/peripheral primitive neuroectodermal tumors of the uterus confirmed with fluorescence in situ hybridization in a 29‐year‐old Chinese female: A case report and published work reviewJournal of Obstetrics and Gynaecology Research, 2014
- Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangementLaboratory Investigation, 2014
- YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription–polymerase chain reaction in formalin-fixed, paraffin-embedded tumorHuman Pathology, 2013
- Cyclin D1 as a Diagnostic Immunomarker for Endometrial Stromal Sarcoma With YWHAE-FAM22 RearrangementAmerican Journal of Surgical Pathology, 2012
- The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal SarcomasAmerican Journal of Surgical Pathology, 2012